On 19 April, the Signo Foundation presented the Profesor Barea Awards 2012, an initiative to highlight and recognize the work of public and private institutions to improve health management and development of new initiatives that seek to optimize the healthcare services. In the category “Healthcare facilities and service companies: Global Management” has been awarded the […]
The integration of different levels of information associated with a disease, such as issues related to environmental exposure, epigenetics, genetics, genomics, metabolomics, transcriptomics and proteomics, requires the development of innovative designs and new methodological tools. The head of the research group on Molecular Epidemiology and Genetics at the Spanish National Cancer Research Centre (CNIO), Núria
On Wednesday April 25 we commemorate the national day of cystic fibrosis, one of the most common serious genetic diseases, affecting one in five thousand births. The Human Molecular Genetics research group at IDIBELL searches new treatments for cystic fibrosis, both from a functional approach and from the development of gene therapies. The research carried
IDIBELL researches to cure cystic fibrosis Read More »
One of the foremost experts in the field of multiple myeloma, Jesus San Miguel, explained in IDIBELL seminar series on 13 April, the approach to this disease that makes his research group at the University Hospital of Salamanca. The researcher explained that one objective is to understand the pathogenesis of the disease: “We want to
The researcher Manel Esteller, director of the Cancer and Epigenetics Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), Professor of Genetics at the University of Barcelona and ICREA Research Professor has chosen Academic Elect of the Royal Academy of Medicine of Catalonia (RAMC). Esteller will occupy the space left by Moises Broggi, Creu de
Manel Esteller, chosen Elect Academic of the Royal Academy of Medicine of Catalonia Read More »
IDIBELL researcher Oriol Casanovas has published in the latest issue of Nature an article titled “Limitations of therapies exposed” where he highlights the need to know the limitations of antiangiogenic therapies to open doors to new combinations and therapeutic approaches that involve greater benefits for patients. Specifically, Casanovas comments two recent publications which expose the
Oriol Casanovas reviews limitations of antiangiogenic therapies at Nature Read More »
The scientific journal Nature includes in its issue of March 29th an article that analyzes investment opportunities and development of scientific careers in the field of epigenetics. In the article, the director of the Cancer Epigenetics and Biology Program of the IDIBELL, ICREA researcher and professor at the University of Barcelona, Manel Esteller, highlights the
IDIBELL, epigenetics and scientific career at Nature Read More »
Researchers from the IDIBELL have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that the modulation of the levels of this protein could be a new therapeutic strategy to prevent lung metastases. The study results have been advanced in the
The newspaper La Vanguardia publishes today an article written by the IDIBELL general manager, Emilià Pola, warning about the low priority given to innovation in our country. Pola highlights the paradox that “while Spain is the first country in the world to perform the most complex surgeries [referring to transplantations] and our hospitals are an
La Vanguardia publishes an article on innovation, by the IDIBELL general manager Read More »
The journal Computers in Biology and Medicine has published an article on the new IT application BootstRatio, created by IDIBELL researchers. The application allows online statistical analysis of data from gene expression. It is accessible through http://regstattools.net/br and any scientist is already to use it. Article’s reference Clèries R., Galvez J., Espino M., Ribes
